Prazosin induced lysosomal tubulation interferes with cytokinesis and the endocytic sorting of the tumour antigen CD98hc-Reference-Cited by-同舟云学术

Prazosin induced lysosomal tubulation interferes with cytokinesis and the endocytic sorting of the tumour antigen CD98hc

Published:2018-09 Issue:9 Volume:1865 Page:1211-1229
ISSN:0167-4889
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

Author:

Fuchs Robert,Stracke Anika,Holzmann Viktoria,Luschin-Ebengreuth Gerfried,Meier-Allard Nathalie,Ebner Nadine,Lassacher Teresa Maria,Absenger-Novak Markus,Fröhlich Eleonore,Schittmayer Matthias,Cano Crespo Sara,Palacin Manuel,Rinner Beate,Birner-Gruenberger Ruth

Funder

Austrian Science Fund

Spanish Ministry of Science and Innovation

Government of Catalonia

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference76 articles.

1. Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor-independent action;Benning;Cancer Res.,2002

2. Doxazosin induces apoptosis in cardiomyocytes cultured in vitro by a mechanism that is independent of alpha1-adrenergic blockade;Gonzalez-Juanatey;Circulation,2003

3. Alpha1-adrenergic receptor antagonists: novel therapy for pituitary adenomas;Fernando;Mol. Endocrinol.,2005

4. The alpha1-adrenergic receptor antagonist doxazosin inhibits EGFR and NF-kappaB signalling to induce breast cancer cell apoptosis;Hui;Eur. J. Cancer,2008

5. alpha1-Adrenergic drugs modulate differentiation and cell death of human erythroleukemia cells through non adrenergic mechanism;Fuchs;Exp. Cell Res.,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive review of the repositioning of non-oncologic drugs for cancer immunotherapy;Medical Oncology;2024-04-23

2. The alpha-adrenergic antagonist prazosin promotes cytosolic siRNA delivery from lysosomal compartments;Journal of Controlled Release;2023-12

3. Development of a high affinity Anticalin® directed against human CD98hc for theranostic applications;Theranostics;2020